MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
- PMID: 19196972
- PMCID: PMC2651305
- DOI: 10.1073/pnas.0805854106
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
Abstract
N-methyl-D-aspartate (NMDA) glutamate receptors are regulators of fast neurotransmission and synaptic plasticity in the brain. Disruption of NMDA-mediated glutamate signaling has been linked to behavioral deficits displayed in psychiatric disorders such as schizophrenia. Recently, noncoding RNA molecules such as microRNAs (miRNAs) have emerged as critical regulators of neuronal functions. Here we show that pharmacological (dizocilpine) or genetic (NR1 hypomorphism) disruption of NMDA receptor signaling reduces levels of a brain-specific miRNA, miR-219, in the prefrontal cortex (PFC) of mice. Consistent with a role for miR-219 in NMDA receptor signaling, we identify calcium/calmodulin-dependent protein kinase II gamma subunit (CaMKIIgamma), a component of the NMDA receptor signaling cascade, as a target of miR-219. In vivo inhibition of miR-219 by specific antimiR in the murine brain significantly modulated behavioral responses associated with disrupted NMDA receptor transmission. Furthermore, pretreatment with the antipsychotic drugs haloperidol and clozapine prevented dizocilpine-induced effects on miR-219. Taken together, these data support an integral role for miR-219 in the expression of behavioral aberrations associated with NMDA receptor hypofunction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment in
-
MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia.Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):2975-6. doi: 10.1073/pnas.0813321106. Epub 2009 Feb 26. Proc Natl Acad Sci U S A. 2009. PMID: 19251669 Free PMC article. No abstract available.
Similar articles
-
Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.J Neurosci. 2001 Jan 15;21(2):750-7. doi: 10.1523/JNEUROSCI.21-02-00750.2001. J Neurosci. 2001. PMID: 11160454 Free PMC article.
-
miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats.Oncotarget. 2017 Apr 25;8(17):28203-28214. doi: 10.18632/oncotarget.15997. Oncotarget. 2017. PMID: 28423675 Free PMC article.
-
Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.Neuroscience. 2005;132(4):1035-43. doi: 10.1016/j.neuroscience.2005.02.006. Neuroscience. 2005. PMID: 15857708
-
Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.Ann N Y Acad Sci. 2006 Nov;1086:160-8. doi: 10.1196/annals.1377.003. Ann N Y Acad Sci. 2006. PMID: 17185514 Review.
-
Targeting NMDA receptor signaling for therapeutic intervention in brain disorders.Rev Neurosci. 2023 Jan 2;34(6):635-647. doi: 10.1515/revneuro-2022-0096. Print 2023 Aug 28. Rev Neurosci. 2023. PMID: 36586105 Review.
Cited by
-
Approaches to manipulating microRNAs in neurogenesis.Front Neurosci. 2013 Jan 17;6:196. doi: 10.3389/fnins.2012.00196. eCollection 2012. Front Neurosci. 2013. PMID: 23335878 Free PMC article.
-
The Vast Complexity of the Epigenetic Landscape during Neurodevelopment: An Open Frame to Understanding Brain Function.Int J Mol Sci. 2018 May 1;19(5):1333. doi: 10.3390/ijms19051333. Int J Mol Sci. 2018. PMID: 29723958 Free PMC article. Review.
-
MicroRNA: implications in HIV, a brief overview.J Neurovirol. 2011 Oct;17(5):416-23. doi: 10.1007/s13365-011-0046-1. Epub 2011 Jul 23. J Neurovirol. 2011. PMID: 21786074 Free PMC article. Review.
-
Functions of noncoding RNAs in neural development and neurological diseases.Mol Neurobiol. 2011 Dec;44(3):359-73. doi: 10.1007/s12035-011-8211-3. Epub 2011 Oct 4. Mol Neurobiol. 2011. PMID: 21969146 Free PMC article. Review.
-
Altered Translational Control of Fragile X Mental Retardation Protein on Myelin Proteins in Neuropsychiatric Disorders.Biomol Ther (Seoul). 2017 May 1;25(3):231-238. doi: 10.4062/biomolther.2016.042. Biomol Ther (Seoul). 2017. PMID: 27829268 Free PMC article. Review.
References
-
- Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci. 2007;8:413–426. - PubMed
-
- Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiatry. 1996;3:241–253. - PubMed
-
- Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 2001;57:1618–1628. - PubMed
-
- Javitt DC. Glutamate and Schizophrenia: Phencyclidine, N-Methyl-d-Aspartate Receptors, and Dopamine-Glutamate Interactions. Int Rev Neurobiol. 2007;78:69–108. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
